# Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
Canonical URL: https://biopharmsignal.com/news/RLMD/relmada-therapeutics-provides-regulatory-update-confirming-fda-alignment-on-registrational-studies-design-for-ndv-01-for-two-separate-indications
Ticker: RLMD
Company: Relmada
Source: Relmada
Published: 2026-01-12 12:00 EST
Original Source URL: https://www.relmada.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-28 12:30 EST — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11) — Source: Relmada
- 2026-07-16 11:05 EST — [Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-to-report-second-quarter-2026-financial-results-on-thursday-a5332b5c) — Source: Relmada
- 2026-06-29 11:00 EST — [Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-joins-russell-2000-and-russell-3000-indexes-f3211c84) — Source: Relmada
- 2026-06-11 11:00 EST — [Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-cns-drug-development-veteran-michael-quirk-as-seni-41648713) — Source: Relmada
- 2026-05-28 11:00 EST — [Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-to-present-at-the-jefferies-global-healthcare-conference) — Source: Relmada
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)